Why psychiatry needs better patient outcome data on medical cannabis
Dr Imogen Kretzschmar, consultant psychiatrist at Mamedica, examines medical cannabis's mental health benefits for patients under specialist supervision. Dr Imogen…
Analysis
FDA leadership in flux, but core operations remain stable, former FDA staff say
Site success in clinical trials begins with financial certainty
Podcast: Experience as a patient in a first-in-human clinical trial
What happens when protocol data finally flows
H1 2026 clinical trials: China, funding and technology set the agenda
Participant enrolment and retention key to clinical trial derisking
Three PsA trials to watch in 2026
